Replies to post #148075 on Cytodyn Inc (CYDY)

[misiu143]

Stock Jedi , I read this particular article in the past , and I overlooked in your previous post..

Here Dr J Woodcock spoke ONLY about developing other NEUTRALIZING monoclonal antibodies , not Leronlimab..

[that_little_voice]

Even if that is true, CYDY would need to run another study showing safety and efficacy.

[misiu143]

In your post..

" Individual monoclonal antibody products be developed with expectation that they will be combined with one or more monoclonal antibody products that bind to DIFFERENT EPITOPES to minimize the risk of long acting against emerging variants.."


Rockleo understood very well I believe , they developing more neutralizing monoclonal antibodies , binding in different place of the virus then present , to cover more mutation..

And recently in a different paper with Dr Woodcocck , she name it , neutralizing monoclonal antibodies , we will be spending more money to develop ..

So really nothing with us IMO..